Should You Buy Lam Research Corp (LRCX) Today? Analysis, Price Targets, and 2026 Outlook.
Analysis Updated At
2026/01/30
Buy now. Despite being technically overbought short-term (RSI>80) and sitting near resistance after an earnings-driven run, Lam Research has strong upside catalysts (AI-driven WFE upcycle, beat-and-raise quarter, broad price-target hikes) and supportive positioning signals (options volume skew to calls, net positive Congress activity). For an impatient buyer who doesn’t want to wait for a pullback, the probability-weighted setup favors owning it now rather than trying to time a better entry.
Technical Analysis
Trend is bullish and momentum remains positive, but stretched.
- Moving averages: Bullish stack (SMA_5 > SMA_20 > SMA_200) confirms an established uptrend.
- MACD: Histogram +1.559 and expanding indicates strengthening upside momentum.
- RSI(6): 82.0 signals overbought conditions—near-term consolidation/pullback risk is elevated.
- Key levels: Pivot 231.05; Resistance R1 245.38 (price 244.66 is just below it), R2 254.23; Support S1 216.72.
- Tape context: Regular session -3.59% and post-market -1.41% after a pre-market pop suggests some profit-taking after strong news, but not a clear trend break.
- Pattern-based short-horizon stats provided: ~+0.71% next day, -2.24% next week, +0.63% next month (implies choppy near-term).
**Intellectia Proprietary Trading Signals**
- [AI Stock Picker](module://ai_stock_pick): No signal on given stock today.
- [SwingMax](module://swingmax): No signal on given stock recently.
Analyst Ratings and Price Target Trends
Recent trend: Strongly positive—multiple firms raised price targets sharply after the Q2 report, with most maintaining Buy/Outperform; one notable holdout kept an Equal Weight.
- Oppenheimer: PT to $265 (from $200), Outperform; calls LRCX top pick and best-positioned for AI-driven demand.
- Goldman Sachs: PT to $262 (from $180), Buy; expects shares to trade higher post beat/guidance.
- Citi: PT to $300 (from $265), Buy; frames LRCX in an "upcycle" with further upside.
- Mizuho: PT to $295 (from $265), Outperform.
- Barclays: PT to $250 (from $195), Equal Weight (more cautious vs peers).
Wall Street pros: Upcycle/AI WFE tailwinds, strong execution, etch/deposition exposure, upbeat 2026 spending outlook.
Wall Street cons: After a big run, near-term valuation/positioning can be crowded; some analysts remain less aggressive (Equal Weight) despite better guidance.
Wall Street analysts forecast LRCX stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for LRCX is 192.5 USD with a low forecast of 142 USD and a high forecast of 265 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Wall Street analysts forecast LRCX stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for LRCX is 192.5 USD with a low forecast of 142 USD and a high forecast of 265 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Current: 248.170
Current: 248.170
